Quantcast

Latest Autoimmunity Stories

2014-03-31 16:27:04

Health Insurance Claim Data Suggests Value of Screening BOSTON, March 31, 2014 /PRNewswire-USNewswire/ -- Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data. The study, published online March 31, 2014 in JAMA Neurology, is the largest to date to look at the association between autoimmune disease and epilepsy without a recognized...

2014-03-28 09:26:17

A combination of genetic predisposition and environmental factors is believed to cause autoimmune (type 1) diabetes. A study published on March 27th in PLOS Pathogens gets at the mechanisms by which rotavirus infection contributes to autoimmune diabetes in a mouse model of the disease. NOD (for non-obese diabetic) mice are prone to develop diabetes, and infection with rotavirus accelerates onset of the disease. Barbara Coulson and colleagues, from The University of Melbourne, Australia,...

2014-03-25 08:28:54

PETACH TIKVA, Israel, March 25, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has been invited to present at the upcoming 9(th) International Congress of Autoimmunity. The conference will be held on March 26-30, 2014 at Nice Acropolis Convention Center in Nice, France. On Friday March 28(th), 16:30, Can-Fite...

2014-03-24 23:03:27

The Autoimmunity Bible And Norton Protocol created by Julia Liu is a newly updated system that teaches people how to treat autoimmune disorders at home. A complete review on the site Vkool.com points out whether or not this program is safe for people to use. Seattle, WA (PRWEB) March 24, 2014 The Autoimmunity Bible And Norton Protocol is the latest e-guide developed by Julia Liu, who promises to help autoimmune diseases treat their condition effectively without using any kind of harmful...

2014-03-20 12:32:58

LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL((TM))(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential...

2014-03-17 12:27:32

--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, March 17, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of clinical studies with its lead compound RSLV-132. Resolve administered the first doses to humans of RSLV-132 its first-in-class targeted nuclease therapy designed to decrease the burden of circulating RNA-containing immune complexes in SLE patients. Ongoing studies are designed to evaluate the safety, tolerability,...

2014-03-12 04:21:02

CARMEL, Calif., March 12, 2014 /PRNewswire/ -- Autoimmune diseases are one of the top 10 leading causes of death in female children and women in all age groups up to 64 years of age. While common immunosuppressant treatments frequently lead to devastating long-term side effects, the NIH estimates up to 23.5 million Americans suffer from autoimmune disease and that number is rising. Life is a significant challenge for those suffering from autoimmune disorders. Many continue to struggle...

2014-03-07 12:25:28

TBG and TNIB join forces to address the critical need for quality treatments to combat chronic, life-threatening diseases in developing countries around the world MINNEAPOLIS and ORLANDO, Fla., March 7, 2014 /PRNewswire/ -- The Brewer Group, Inc. ("TBG") a global investment advisory firm, today announced a new strategic partnership with TNI BioTech, Inc. ("TNIB") (OTCQB: TNIB), a biotechnology company pioneering the development of innovative therapies for autoimmune diseases by...

Critical Link Between Obesity And Diabetes Identified
2014-03-07 09:09:00

Beth Israel Deaconess Medical Center Working via the immune system, the RBP4 molecule leads to inflammation of fat tissue and increased risk of diabetes It's by now well established that obesity is a major risk factor for diabetes. But what exactly is it about extra body fat that leads to insulin resistance and blood glucose elevation, the hallmarks of diabetes? Over the past several years, Beth Israel Deaconess Medical Center (BIDMC) endocrinologist Barbara Kahn, MD, has developed...

2014-03-03 08:30:54

PETACH TIKVA, Israel, March 3, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the addition of a key opinion leader, medical and industry expert, Dr. Lee S. Simon, as consultant to assist in the regulatory and clinical development of the company's CF101 rheumatoid arthritis program. The need to bring Dr. Simon on board...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related